Transfusion dependence development and disease evolution in patients with MDS and del(5q) and without transfusion needs at diagnosis-Reference-Cited by-同舟云学术

Transfusion dependence development and disease evolution in patients with MDS and del(5q) and without transfusion needs at diagnosis

Published:2014-03 Issue:3 Volume:38 Page:304-309
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Rojas Silvia M.,Díez-Campelo María,Luño Elisa,Cabrero Mónica,Pedro Carme,Calabuig Marisa,Nomdedeu Benet,Cedena Teresa,Arrizabalaga Beatriz,García Marta,Cerveró Carlos,Collado Rosa,Azaceta Gemma,Ardanaz Mª Teresa,Muñoz Juan Antonio,Xicoy Blanca,Rodríguez Mª José Requena,Bargay Joan,Morell Mª Jesús Arilla,Simiele Adriana,del Cañizo Consuelo

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference27 articles.

1. Myelodisplastic syndromes;Tefferi;N Engl J Med,2009

2. International Scoring System for evaluating prognosis in Myelodysplastic syndromes;Greenberg;Blood,1997

3. Revised international prognostic scoring system for myelodysplastic syndromes;Greenberg;Blood,2012

4. Distinct haematological disorder with deletion of long arm of no. 5 chromosome;Van den Berghe;Nature,1974

5. The World Health Organization (WHO) classification of the myeloid neoplasms;Vardiman;Blood,2002

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low dose lenalidomide versus placebo in non-transfusion dependent patients with low risk, del(5q) myelodysplastic syndromes (SintraREV): a randomised, double-blind, phase 3 trial;The Lancet Haematology;2024-09

2. Evolution of severe (transfusion‐dependent) anaemia in myelodysplastic syndromes with 5q deletion is characterized by a macrophage‐associated failure of the eythropoietic niche;British Journal of Haematology;2022-04

3. Part 4: Myelodysplastic syndromes—Treatment of low-risk patients with the 5q deletion;Hematology, Transfusion and Cell Therapy;2018-07

4. Association between Transfusion Status and Overall Survival in Patients with Myelodysplastic Syndromes: A Systematic Literature Review and Meta-Analysis;Acta Haematologica;2016

5. Lenalidomide treatment induced the normalization of marker protein levels in blood plasma of patients with 5q-myelodysplastic syndrome;GEN PHYSIOL BIOPHYS;2015